Trexquant Investment’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.99M | Buy |
+3,668
| New | +$2.07M | 0.01% | 1194 |
|
|
2026
Q1 | – | Sell |
-12,334
| Closed | -$6.01M | – | 2068 |
|
|
2025
Q4 | $6.01M | Buy |
+12,334
| New | +$5.74M | 0.05% | 509 |
|
|
2025
Q3 | – | Sell |
-28,284
| Closed | -$8.13M | – | 1932 |
|
|
2025
Q2 | $8.13M | Buy |
28,284
+19,365
| +217% | +$5.79M | 0.09% | 331 |
|
|
2025
Q1 | $2.75M | Buy |
+8,919
| New | +$3.06M | 0.03% | 749 |
|
|
2024
Q4 | – | Sell |
-2,973
| Closed | -$1.07M | – | 1871 |
|
|
2024
Q3 | $1.07M | Buy |
+2,973
| New | +$1M | 0.01% | 1029 |
|
|
2024
Q2 | – | Sell |
-30,796
| Closed | -$7.07M | – | 1866 |
|
|
2024
Q1 | $7.07M | Buy |
30,796
+10,990
| +55% | +$2.48M | 0.14% | 203 |
|
|
2023
Q4 | $4.36M | Buy |
19,806
+5,770
| +41% | +$1.33M | 0.1% | 297 |
|
|
2023
Q3 | $3.17M | Buy |
+14,036
| New | +$3.23M | 0.08% | 348 |
|
|
2023
Q2 | – | Sell |
-10,493
| Closed | -$2.35M | – | 1824 |
|
|
2023
Q1 | $2.35M | Buy |
+10,493
| New | +$2.59M | 0.06% | 399 |
|
|
2022
Q3 | – | Sell |
-4,402
| Closed | -$1.04M | – | 1858 |
|
|
2022
Q2 | $1.04M | Sell |
4,402
-340
| -7% | -$69.1K | 0.05% | 500 |
|
|
2022
Q1 | $851K | Buy |
4,742
+2,137
| +82% | +$407K | 0.04% | 532 |
|
|
2021
Q4 | $563K | Sell |
2,605
-3,002
| -54% | -$589K | 0.03% | 587 |
|
|
2021
Q3 | $1.03M | Buy |
+5,607
| New | +$1.1M | 0.08% | 310 |
|
|
2020
Q4 | – | Sell |
-11,174
| Closed | -$1.13M | – | 1512 |
|
|
2020
Q3 | $1.13M | Buy |
11,174
+9,370
| +519% | +$1.03M | 0.07% | 374 |
|
|
2020
Q2 | $218K | Sell |
1,804
-9,968
| -85% | -$1.12M | 0.02% | 1021 |
|
|
2020
Q1 | $1.12M | Sell |
11,772
-5,859
| -33% | -$557K | 0.08% | 380 |
|
|
2019
Q4 | $1.55M | Sell |
17,631
-318
| -2% | -$28K | 0.09% | 272 |
|
|
2019
Q3 | $1.43M | Sell |
17,949
-32,471
| -64% | -$2.61M | 0.12% | 222 |
|
|
2019
Q2 | $3.94M | Buy |
+50,420
| New | +$4.71M | 0.35% | 82 |
|
|
2018
Q4 | – | Sell |
-3,987
| Closed | -$510K | – | 1319 |
|
|
2018
Q3 | $510K | Buy |
+3,987
| New | +$493K | 0.04% | 531 |
|
|
2018
Q2 | – | Sell |
-2,368
| Closed | -$266K | – | 1243 |
|
|
2018
Q1 | $266K | Buy |
+2,368
| New | +$301K | 0.02% | 859 |
|
|
2017
Q4 | – | Sell |
-4,086
| Closed | -$479K | – | 1271 |
|
|
2017
Q3 | $479K | Buy |
+4,086
| New | +$522K | 0.12% | 288 |
|
|
2016
Q2 | – | Sell |
-19,900
| Closed | -$2.22M | – | 1123 |
|
|
2016
Q1 | $2.22M | Buy |
19,900
+13,600
| +216% | +$1.72M | 0.26% | 85 |
|
|
2015
Q4 | $987K | Buy |
+6,300
| New | +$917K | 0.09% | 397 |
|
Other funds holding UTHR
ACA
JT
Trexquant Investment's UTHR Position: Q2 2026 in Review
Trexquant Investment opened a new position in United Therapeutics (UTHR) in Q2 2026: 3,668 shares worth $1.99M. The stake represents 0.01% of the portfolio and ranks #1194 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in UTHR as recently as Q4 2025.
Trexquant Investment first reported a position in UTHR in Q4 2015 and has held it in 24 quarters since. The position peaked at $8.13M in Q2 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Trexquant Investment held 3,668 shares of United Therapeutics worth $1.99M as of Q2 2026.
- United Therapeutics was a new Trexquant Investment position in Q2 2026.
- United Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1194 holding.
- Trexquant Investment first reported a position in United Therapeutics in Q4 2015 and has held it in 24 quarters since.
- Trexquant Investment's United Therapeutics position peaked at $8.13M in Q2 2025.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.